NCT06150443

Pilot Study Evaluating the Elasticity and Shear Wave Modulus (Stiffness) of the Median Nerve in Patients With Mild to Moderate Idiopathic Carpal Tunnel Syndrome Receiving OMT and Conservative Therapy

Name: Clinical Trial NCT06150443
Creator: Kettering Health Network
Keywords: Carpal Tunnel Syndrome, Osteopathic manipulative treatment (OMT), other, clinical trial

Kettering Health Network·ClinicalTrials.gov·otherNot yet recruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Carpal Tunnel Syndrome
Drug/Device/Intervention: Osteopathic manipulative treatment (OMT)
Study type: Interventional
Intervention type: other

Sponsor & location

Primary sponsor: Kettering Health Network

Timeline & enrollment

Phase: N/A
Start date: Mar 01, 2024
End date: Sep 01, 2025
Enrollment: 36 participants

Primary outcome

Elasticity of median nerve at the carpal tunnel inlet,Cross-sectional area of median nerve in 3 locations,Quick DASH Patient Survey Score,CTS-6 Evaluation Tool Score,Elasticity of the transverse carpal ligament,Elasticity of the subsynovial connective tissue in the carpal tunnel

Summary

To evaluate and quantify changes in the elasticity and shear wave modulus (stiffness) of the median nerve in patients diagnosed with mild to moderate carpal tunnel syndrome following osteopathic manipulative therapy.

ICD-10 classifications

Carpal tunnel syndromeTarsal tunnel syndromeArthrosis of first carpometacarpal joint, unspecifiedArthrosis of first carpometacarpal jointOther specified disorders of synovium and tendon

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06150443
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06150443 through Pure Global AI's free database. This phase not specified trial is sponsored by Kettering Health Network and is currently Not yet recruiting. The study focuses on Carpal Tunnel Syndrome. Target enrollment is 36 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.